The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells

Kidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD), which can progress to end stage renal disease (ESRD), are a worldwide health burden. Organ transplantation or kidney dialysis are the only effective available therapeutic tools. Therefore, in vitro models of kidne...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Lisa Nguyen, Wasco Wruck, Lars Erichsen, Nina Graffmann, James Adjaye
Format: Artykuł
Język:English
Wydane: MDPI AG 2022-02-01
Seria:Cells
Hasła przedmiotowe:
Dostęp online:https://www.mdpi.com/2073-4409/11/4/635
_version_ 1827656366996586496
author Lisa Nguyen
Wasco Wruck
Lars Erichsen
Nina Graffmann
James Adjaye
author_facet Lisa Nguyen
Wasco Wruck
Lars Erichsen
Nina Graffmann
James Adjaye
author_sort Lisa Nguyen
collection DOAJ
description Kidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD), which can progress to end stage renal disease (ESRD), are a worldwide health burden. Organ transplantation or kidney dialysis are the only effective available therapeutic tools. Therefore, in vitro models of kidney diseases and the development of prospective therapeutic options are urgently needed. Within the kidney, the glomeruli are involved in blood filtration and waste excretion and are easily affected by changing cellular conditions. Puromycin aminonucleoside (PAN) is a nephrotoxin, which can be employed to induce acute glomerular damage and to model glomerular disease. For this reason, we generated kidney organoids from three iPSC lines and treated these with PAN in order to induce kidney injury. Morphological observations revealed the disruption of glomerular and tubular structures within the kidney organoids upon PAN treatment, which were confirmed by transcriptome analyses. Subsequent analyses revealed an upregulation of immune response as well as inflammatory and cell-death-related processes. We conclude that the treatment of iPSC-derived kidney organoids with PAN induces kidney injury mediated by an intertwined network of inflammation, cytoskeletal re-arrangement, DNA damage, apoptosis and cell death. Furthermore, urine-stem-cell-derived kidney organoids can be used to model kidney-associated diseases and drug discovery.
first_indexed 2024-03-09T22:21:36Z
format Article
id doaj.art-dbc5dba3ca4045e9b63aa236ce45c163
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T22:21:36Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-dbc5dba3ca4045e9b63aa236ce45c1632023-11-23T19:14:29ZengMDPI AGCells2073-44092022-02-0111463510.3390/cells11040635The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem CellsLisa Nguyen0Wasco Wruck1Lars Erichsen2Nina Graffmann3James Adjaye4Institute of Stem Cell Research and Regenerative Medicine, Medical Faculty, Heinrich-Heine University, 40225 Dusseldorf, GermanyInstitute of Stem Cell Research and Regenerative Medicine, Medical Faculty, Heinrich-Heine University, 40225 Dusseldorf, GermanyInstitute of Stem Cell Research and Regenerative Medicine, Medical Faculty, Heinrich-Heine University, 40225 Dusseldorf, GermanyInstitute of Stem Cell Research and Regenerative Medicine, Medical Faculty, Heinrich-Heine University, 40225 Dusseldorf, GermanyInstitute of Stem Cell Research and Regenerative Medicine, Medical Faculty, Heinrich-Heine University, 40225 Dusseldorf, GermanyKidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD), which can progress to end stage renal disease (ESRD), are a worldwide health burden. Organ transplantation or kidney dialysis are the only effective available therapeutic tools. Therefore, in vitro models of kidney diseases and the development of prospective therapeutic options are urgently needed. Within the kidney, the glomeruli are involved in blood filtration and waste excretion and are easily affected by changing cellular conditions. Puromycin aminonucleoside (PAN) is a nephrotoxin, which can be employed to induce acute glomerular damage and to model glomerular disease. For this reason, we generated kidney organoids from three iPSC lines and treated these with PAN in order to induce kidney injury. Morphological observations revealed the disruption of glomerular and tubular structures within the kidney organoids upon PAN treatment, which were confirmed by transcriptome analyses. Subsequent analyses revealed an upregulation of immune response as well as inflammatory and cell-death-related processes. We conclude that the treatment of iPSC-derived kidney organoids with PAN induces kidney injury mediated by an intertwined network of inflammation, cytoskeletal re-arrangement, DNA damage, apoptosis and cell death. Furthermore, urine-stem-cell-derived kidney organoids can be used to model kidney-associated diseases and drug discovery.https://www.mdpi.com/2073-4409/11/4/635urine cellsiPSCsorganoidspuromycin aminonucleosideAKIinflammation
spellingShingle Lisa Nguyen
Wasco Wruck
Lars Erichsen
Nina Graffmann
James Adjaye
The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells
Cells
urine cells
iPSCs
organoids
puromycin aminonucleoside
AKI
inflammation
title The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells
title_full The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells
title_fullStr The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells
title_full_unstemmed The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells
title_short The Nephrotoxin Puromycin Aminonucleoside Induces Injury in Kidney Organoids Differentiated from Induced Pluripotent Stem Cells
title_sort nephrotoxin puromycin aminonucleoside induces injury in kidney organoids differentiated from induced pluripotent stem cells
topic urine cells
iPSCs
organoids
puromycin aminonucleoside
AKI
inflammation
url https://www.mdpi.com/2073-4409/11/4/635
work_keys_str_mv AT lisanguyen thenephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells
AT wascowruck thenephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells
AT larserichsen thenephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells
AT ninagraffmann thenephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells
AT jamesadjaye thenephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells
AT lisanguyen nephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells
AT wascowruck nephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells
AT larserichsen nephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells
AT ninagraffmann nephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells
AT jamesadjaye nephrotoxinpuromycinaminonucleosideinducesinjuryinkidneyorganoidsdifferentiatedfrominducedpluripotentstemcells